← Eichor
Condition: Purine Metabolism Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Purine Metabolism Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Phase 2 · 17 location(s) · Crystalys Therapeutics · NCT07535034Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Sy
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT05927688Dose Response of Exercise for Arthritis Management
NA · 1 location(s) · University of South Carolina · NCT06880653Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05546593A Study of Dotinurad Versus Allopurinol in Participants With Gout
Phase 3 · 100 location(s) · Crystalys Therapeutics · NCT07089875B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis
EARLY_Phase 1 · 2 location(s) · Jinling Hospital, China · NCT06612411Effect of Dotinurad in Hyperuricemia With Hypertension
Phase 4 · 1 location(s) · Saga University · NCT06834230Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Phase 4 · 7 location(s) · Massachusetts General Hospital · NCT04875702The Orienting Study
Phase N/A · 1 location(s) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT07504146SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial
Phase 4 · 1 location(s) · Massachusetts General Hospital · NCT06674109Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Phase 2 · 38 location(s) · Atom Therapeutics Co., Ltd · NCT07145229Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic C
Phase 2 · 21 location(s) · UNICANCER · NCT06245356Time Required to Dissolve Urate Deposits
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06669000Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
Phase 3 · 6 location(s) · University Hospital, Rouen · NCT05109936Metformin in Safety and Efficacy in Gouty Patients
Phase 2 · 1 location(s) · Mostafa Bahaa · NCT06924658Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT06629376CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies
Phase N/A · 1 location(s) · Lille Catholic University · NCT04695028Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese No
Phase 2 · 1 location(s) · Mostafa Bahaa · NCT06995339Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets
Phase 4 · 1 location(s) · Huashan Hospital · NCT06966635Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis
Phase 3 · 1 location(s) · Laboratorios Silanes S.A. de C.V. · NCT06863701Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares
Phase 4 · 1 location(s) · Massachusetts General Hospital · NCT07346079Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Phase N/A · 1 location(s) · University of Bonn · NCT07150000Improving Gout Care After an ED Visit
NA · 1 location(s) · University of Alabama at Birmingham · NCT06534554The Remote Monitoring of Gout Feasibility Study in Primary Care
NA · 1 location(s) · Diakonhjemmet Hospital · NCT07490522Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Phase N/A · 1 location(s) · Osaka Metropolitan University · NCT06694012Tigulixostat (IBI128) vs Febuxostat in Gout
Phase 3 · 1 location(s) · Innovent Biologics Technology Limited (Shanghai R&D Center) · NCT07414394A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens,
Phase 2 · 27 location(s) · Protalix · NCT07280156Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Phase 2/Phase 3 · 40 location(s) · Olatec Therapeutics, Inc. · NCT05658575A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.
Phase 1 · 1 location(s) · Shanghai Institute Of Biological Products · NCT06298071Nurse-Led Telehealth for Gout
NA · 5 location(s) · University of Aarhus · NCT06971146
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.